Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Concha Delgado-Sanz"'
Autor:
Amparo Larrauri, Raquel Yotti, Concha Delgado-Sanz, Miguel Martín, Israel Cruz, Roberto Pastor-Barriuso, Aurora Fernández-García, Inmaculada León-Gómez, Marina Pollán, Jesús Oteo-Iglesias, Beatriz Pérez-Gómez, Juan F Muñoz-Montalvo, Mayte Pérez-Olmeda, de Larrea Nf, Jose L Sanmartín, Pablo Fernández-Navarro, Jose León Paniagua, Miguel A. Hernán, Faustino Blanco
ObjectiveTo estimate the range of the age- and sex-specific infection fatality risk (IFR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on confirmed coronavirus disease 2019 (COVID-19) deaths and excess all-cause deaths.Desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b8fab8b0d3ee306e6ff51159b83f607
https://doi.org/10.1101/2020.08.06.20169722
https://doi.org/10.1101/2020.08.06.20169722
Autor:
Manuel García-Cenoz, L Etxebarriarteun-Aranzabal, Francisco Pozo, Tomás Vega, D Castrillejo, R Sancho, J Giménez, Esteban Martínez, Carmen Quiñones, Angela Domínguez García, J M Vanrell, Inmaculada Casas, Concha Delgado-Sanz, Amparo Larrauri, S De Mateo, Silvia Jiménez-Jorge, Jesús Castilla
Publikováno v:
Scopus-Elsevier
Repisalud
Instituto de Salud Carlos III (ISCIII)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3561bfc0d9dbd5dfa6d771f7154ad911
https://doi.org/10.2807/1560-7917.es2014.19.9.20727
https://doi.org/10.2807/1560-7917.es2014.19.9.20727
Autor:
Virtudes Gallardo, F Carril, Manuel García-Cenoz, Carmen Quiñones, E Pérez, Nuria Torner, S De Mateo, Silvia Jiménez-Jorge, A. Martinez, Tomás Vega, Amparo Larrauri, José Ramos, Jone M. Altzibar, Esteban Martínez, J M Vanrell, Jesús Castilla, Concha Delgado-Sanz, J Giménez, Francisco Pozo, Inmaculada Casas, M C Serrano, Cristina Carranza Rodríguez, D Castrillejo
Publikováno v:
Scopus-Elsevier
Repisalud
Instituto de Salud Carlos III (ISCIII)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Published Erratum Euro Surveill. 2015 Jul 23;20(29):21190. PMID: 26227373 We aimed to estimate influenza vaccine effectiveness (VE) against laboratory-confirmed influenza during three influenza seasons (2010/11 to 2012/2013) in Spain using surveillan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03fc9a5794566a063ac01ecc38eb359
http://www.scopus.com/inward/record.url?eid=2-s2.0-84937720799&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84937720799&partnerID=MN8TOARS
Autor:
Savulescu, Camelia1 camisav@gmail.com, Silvia Jiménez-Jorge1,2, Concha Delgado-Sanz1,2, Salvador de Mateo1,2, Francisco Pozo3, Inmaculada Casas3, Amparo Larrauri1,2
Publikováno v:
Vaccine. Jul2014, Vol. 32 Issue 35, p4404-4411. 8p.